← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kaps Biotech, Inc.
Williamsville, NY
$1,724,998
Total funding
1
Grants
Funding over time
peak $502.6K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,724,998 · 1
By mechanism
R42$1,724,998 · 1
Investigators at Kaps Biotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis$502,559
R42 · FY2021 · MD
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis$502,137
R42 · FY2022 · MD
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis$495,303
R42 · FY2020 · MD
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis$224,999
R42 · FY2018 · MD